Available clinical trials are below. Click the + sign to expand and review details about their purpose, eligibility criteria, and contact information for study staff. For some studies, you will find a link to ClinicalTrials.gov, where you can explore more information about each study.

NRG-CC014

Study Phase: Phase III

Condition(s): Asymptomatic, high-risk bone metastases from any solid tumor, excluding multiple myeloma
NRG CC014: Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Mulitcenter Randomized Phase 3 Clinical Trial (PREEMPT)

ClinicalTrials.gov NCT ID: NCT06745024

You can view the full clinical description on ClinicalTrials.gov.

View Full Description
profile_amy-grossman

Amy Grossman, RN

Primary Contact - Study Coordinator

484-658-1788
amy.grossman@sluhn.org

profile_william-smith

William H. Smith, MD

Physician - Principal Investigator

NRG-GU011 (PROMETHEAN)

Study Phase: Phase II

Condition(s): Recurrent prostate cancer with oligometastatic disease
Phase II Double-Blinded, Placebo Controlled Trial of Prostate Oligometastatic Radiotherapy With or Without Androgen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG PROMETHEAN)

ClinicalTrials.gov NCT ID: NCT05053152

You can view the full clinical description on ClinicalTrials.gov.

View Full Description
profile_helen-mcgunnigle

Helen McGunnigle

Primary Contact - Study Coordinator

484-658-5044
helen.mcgunnigle@sluhn.org

Bhartesh Shah, MD

Bhartesh Shah, MD

Physician - Principal Investigator

To inquire if you're eligible for a clinical trial, contact: (484) 658-5080, or click here to complete a clinical trial inquiry form.

Cancer Ribbon

Transforming lives through philanthropy

Supporting clinical trials and research can help us create a future where advanced health care is accessible and equitable for everyone. Together, we can transform lives and improve health care for generations to come.

Donate today